Account
Inquiry
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research purposes. This 39-amino acid peptide features two non-natural residues (Aib at positions 2 and 13) and a C20 fatty diacid side chain at Lys20, contributing to its extended half-life.
As a research compound, tirzepatide demonstrates potential mechanisms including enhanced insulin secretion, suppressed glucagon levels, delayed gastric emptying, and reduced appetite in preclinical studies. These properties make it an interesting subject for metabolic research.
Our tirzepatide is supplied as pharmaceutical-grade freeze-dried powder with 99% purity, suitable for research applications only. The product undergoes rigorous quality control including HPLC, MS, and AAA analysis to ensure batch-to-batch consistency.
Available in various research doses from 5mg to 60mg, with custom concentrations available for bulk orders. Each batch is accompanied by comprehensive analytical documentation including COA and MSDS.
For research purposes only. Not for human consumption. Researchers should follow all applicable regulations and guidelines when working with this compound.
